Skip to Main Content

Paper Details

Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury.
BMJ Open
4
2023
Author NameAffiliation
Peter Pickkers
Derek C AngusUniversity of Pittsburgh School of Medicine
Rinaldo BellomoThe University of Melbourne
Rinaldo BellomoAustin Hospital
Michael JoannidisMedical University Innsbruck
Kent DoiThe University of Tokyo Hospital
John A KellumUniversity of Pittsburgh
Pierre-Fran??ois LaterreCliniques Universitaires Saint-Luc
Kathleen D LiuUniversity of California San Fransisco san francisco
Ravindra L MehtaUniversity of California
Patrick T MurrayUniversity College Dublin
Marlies OstermannKing's College London, Guy's & St Thomas' Hospital
Ville Pettil??
Alexander ZarbockUniversitat Munster
  • 1 - 14

Datasets

Release 1.2